Geneoscopy received approval for its noninvasive colorectal cancer screening test, which the FDA designated as a breakthrough device. This marks only the second time the FDA has issued an approval for a molecular diagnostic test for colorectal cancer — and the first time the agency has done so for a colorectal cancer test that uses RNA.
Stand Up To Cancer and Exact Sciences are teaming up to increase colorectal cancer screening awareness and research such that people don't have to die from this preventable disease.
The future looks bright for the integrated specialty pharmacy model – for health systems, providers, and most importantly, for patients.
The Food and Drug Administration has provided a Breakthrough Device Designation for AI Medical Service's' machine learning algorithm that has the ability to analyze endoscopy images for potential diagnosis of gastric cancer.